What is Overwatch Research?
Founded in 2017 and headquartered in Belfast, United Kingdom, Overwatch Research provides a comprehensive software platform engineered to manage the intricacies of preclinical trials. The company addresses the operational bottlenecks inherent in laboratory environments, offering tools that facilitate seamless data collection, real-time task tracking, and regulatory compliance. By digitizing these traditionally manual processes, Overwatch Research enables research organizations to accelerate their development timelines while maintaining high standards of scientific rigor. The company operates at the intersection of health-tech and enterprise software, serving a niche yet high-growth market segment that demands precision and reliability.
How much funding has Overwatch Research raised?
Overwatch Research has raised a total of $3.5M across 1 funding round:
Angel/Seed
$3.5M
Angel/Seed (2021): $3.5M with participation from Frontline Ventures, Techstart Ventures, and SV Angel
Key Investors in Overwatch Research
Frontline Ventures
A venture firm specializing in globally ambitious B2B businesses, providing both seed-stage support and go-to-market expertise for US-to-Europe expansion.
Techstart Ventures
A seed-stage venture capital investor focused on supporting ambitious founding teams in Scotland and Northern Ireland through experienced guidance and equity financing.
SV Angel
A long-term investment firm dedicated to supporting founders by providing strategic insights, essential resources, and access to a vast network to help companies scale.
What's next for Overwatch Research?
With this latest infusion of capital, Overwatch Research is expected to accelerate its product development roadmap and expand its footprint within the global life sciences market. Strategic priorities likely include the integration of advanced analytics capabilities and the scaling of its customer success teams to support a growing roster of international clients. As the company matures, it will likely focus on deepening its ecosystem integrations, ensuring that its platform remains the central nervous system for preclinical research operations. The firm's trajectory suggests a move toward broader enterprise adoption, potentially setting the stage for future growth phases as it continues to refine its value proposition for pharmaceutical and biotech innovators.
See full Overwatch Research company page
